On-demand recording available

The COVID-19 pandemic spurred unprecedented investment and technological innovation in molecular diagnostics as academic, government, and commercial labs rushed to develop faster and cheaper virus detection methods, validate novel sample types, and create multiplexed panels to simultaneously test for similar infections.

Now that COVID-19 has become endemic, what lessons has the healthcare system learned that it can apply to routine respiratory infection testing? What parts of the molecular diagnostics workflow are most in need of additional improvement and innovation?

In this virtual roundtable, our panel of experts who were on the front lines of molecular diagnostic development and deployment during the pandemic will answer these questions and more.